Highlights
NASDAQ: NERV       Minerva Neuroscie
Last Price Today's Change   Day's Range   Trading Volume
6.25   +0.11 (1.79%)  6.05 - 6.27  289,400

Overview

 
Avg Volume (4 weeks):327,800
4 Weeks Range:4.82 - 6.43
4 Weeks Price Volatility (%):
88.82%
52 Weeks Range:4.01 - 8.83
52 Weeks Price Volatility (%):
46.47%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. This portfolio includes four compounds, schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers